Monday, April 28, 2025

11:15 AM - 11:45 AM

Carron 1

---

Details

This session provides an overview of the development and significance of SID in patients with blood cancers, and discusses strategies for reducing infection-related mortality risks in this population. A panel of a haematologist and two immunology experts will highlight how SID, in the context of haematological malignancies, may be more effectively diagnosed and managed, for a patient-centric approach. This promotional symposium is organised and funded by Takeda UK Ltd, and is intended for UK healthcare professionals only. Takeda products will be discussed in this meeting. Prescribing information and adverse event reporting information will be available during the symposium. C-ANPROM/GB/IG/0544 March 2025

---

Speaker